Innate immune mediators in cancer: between defense and resistance
- 26 October 2016
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 274 (1) , 290-306
Abstract
Summary: Chronic inflammation in the tumor microenvironment and evasion of the antitumor effector immune response are two of the emerging hallmarks required for oncogenesis and cancer progression. The innate immune system not only plays a critical role in perpetuating these tumor‐promoting hallmarks but also in developing antitumor adaptive immune responses. Thus, understanding the dual role of the innate system in cancer immunology is required for the design of combined immunotherapy strategies able to tackle established tumors. Here, we review recent advances in the understanding of the role of cell populations and soluble components of the innate immune system in cancer, with a focus on complement, the adapter molecule Stimulator of Interferon Genes, natural killer cells, myeloid cells, and B cells.Keywords
Funding Information
- Instituto de Salud Carlos III
This publication has 230 references indexed in Scilit:
- Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the SpleenCell Reports, 2012
- IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterizationCytokine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceCancer Immunology, Immunotherapy, 2011
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010
- FcRγ Activation Regulates Inflammation-Associated Squamous CarcinogenesisCancer Cell, 2010
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T CellsImmunity, 2008
- Pathogen Recognition and Innate ImmunityCell, 2006